Beam takes its time to the clinic; Aspen gets clearance to test Parkinson's cell therapy in humans
Over a year and a half since Beam Therapeutics received clearance from the FDA to test its base-edited sickle cell therapy in humans, it has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
